Compare DKNG & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DKNG | TECH |
|---|---|---|
| Founded | 2011 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.2B |
| IPO Year | 2021 | 1995 |
| Metric | DKNG | TECH |
|---|---|---|
| Price | $21.67 | $54.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 31 | 13 |
| Target Price | $43.97 | ★ $72.67 |
| AVG Volume (30 Days) | ★ 17.9M | 2.4M |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | ★ 99.05 | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | ★ $6,054,525,000.00 | $1,219,635,000.00 |
| Revenue This Year | $20.16 | $2.49 |
| Revenue Next Year | $14.14 | $6.40 |
| P/E Ratio | ★ N/A | $117.39 |
| Revenue Growth | ★ 26.99 | 5.23 |
| 52 Week Low | $21.01 | $46.02 |
| 52 Week High | $48.78 | $72.16 |
| Indicator | DKNG | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 26.51 | 30.39 |
| Support Level | $21.01 | $48.52 |
| Resistance Level | $36.46 | $58.83 |
| Average True Range (ATR) | 1.30 | 2.86 |
| MACD | -0.28 | -1.11 |
| Stochastic Oscillator | 9.29 | 6.17 |
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. DraftKings is now live with online or retail sports betting in 28 states and i-gaming in 5 states, with both products available to around 40% of Canada's population. In 2024, sports revenue was 61% of total sales, i-gaming 32%, and fantasy and lottery 7%. The company plans to launch a predictive event platform in late 2025 and also operates a non-fungible token commission-based marketplace and develops and licenses online gaming products.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.